Precision NextGen Oncology & Research Center is a clinical research site located in Beverly Hills, California, United States 90212.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Precision NextGen Oncology & Research Center has participated in 6 clinical trials with 6 currently active.
Therapeutic areas: Platinum-resistant Ovarian Cancer, Testicular Cancer, Endometrial Cancer.
Sponsors: Context Therapeutics Inc., Fore Biotherapeutics, Inhibrx Biosciences, Inc.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Precision NextGen Oncology & Research Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Precision NextGen Oncology & Research Center has 6 clinical trials on record, with 6 currently active. Their work covers Platinum-resistant Ovarian Cancer, Testicular Cancer, Endometrial Cancer.
Yes — Precision NextGen Oncology & Research Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.